Simplex Trading’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Simplex Trading’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-340	Closed	-$1.88K	–	10941
2022 Q3	$1K	Sell	340 -8,377	-96%	-$52.6K	﹤0.01%	9745
2022 Q2	$54K	Buy	+8,717	New	+$29.4K	﹤0.01%	6401
2022 Q1	–	Sell	-2,366	Closed	-$8.74K	–	11777
2021 Q4	$11K	Buy	+2,366	New	+$14.3K	﹤0.01%	8981

Simplex Trading's FSTX Position: Q4 2022 in Review

Simplex Trading sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2022, closing a stake of 340 shares — an estimated $1.88K sold.

Simplex Trading first reported a position in FSTX in Q4 2021 and held it in 3 quarters. The position peaked at $54K in Q2 2022. 59 funds tracked by Wall St. Rank hold FSTX as of Q4 2022.

Simplex Trading reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Simplex Trading sold 340 F-star Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1.88K.
Simplex Trading first reported a position in F-star Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Simplex Trading's F-star Therapeutics, Inc. Common Stock position peaked at $54K in Q2 2022.
59 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.